Trevena, Inc.Trevena, Inc.Trevena, Inc.

Trevena, Inc.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪4.12 M‬USD
−2.6752USD
‪−40.29 M‬USD
‪3.13 M‬USD
‪17.90 M‬
Beta (1Y)
1.01

About Trevena, Inc.

CEO
Carrie L. Bourdow
Headquarters
Chesterbrook
Employees (FY)
23
Founded
2007
FIGI
BBG001J1BLF9
Trevena, Inc. is a biopharmaceutical company, which focuses on developing and commercializing novel medicines for patients affected by central nervous system, or CNS, disorders. Its product candidates include Oliceridine injection, TRV250, TRV734, and TRV045. The company was founded by Maxine Gowen, Robert Joseph Lefkowitz, Scott DeWire, Howard A. Rockman, Jonathan Violin, and Erin Whalen on November 9, 2007 and is headquartered in Chesterbrook, PA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of TRVN is 0.2244 USD — it has decreased by 13.99% in the past 24 hours. Watch Trevena, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Trevena, Inc. stocks are traded under the ticker TRVN.
TRVN stock has fallen by 42.46% compared to the previous week, the month change is a 45.27% fall, over the last year Trevena, Inc. has showed a 75.34% decrease.
We've gathered analysts' opinions on Trevena, Inc. future price: according to them, TRVN price has a max estimate of 5.00 USD and a min estimate of 3.00 USD. Watch TRVN chart and read a more detailed Trevena, Inc. stock forecast: see what analysts think of Trevena, Inc. and suggest that you do with its stocks.
TRVN reached its all-time high on Sep 18, 2015 with the price of 339.2500 USD, and its all-time low was 0.1910 USD and was reached on Jun 20, 2024. View more price dynamics on TRVN chart.
See other stocks reaching their highest and lowest prices.
TRVN stock is 18.54% volatile and has beta coefficient of 1.01. Track Trevena, Inc. stock price on the chart and check out the list of the most volatile stocks — is Trevena, Inc. there?
Today Trevena, Inc. has the market capitalization of ‪4.12 M‬, it has increased by 0.90% over the last week.
Yes, you can track Trevena, Inc. financials in yearly and quarterly reports right on TradingView.
Trevena, Inc. is going to release the next earnings report on Aug 8, 2024. Keep track of upcoming events with our Earnings Calendar.
TRVN earnings for the last quarter are −0.36 USD per share, whereas the estimation was −0.47 USD resulting in a 23.40% surprise. The estimated earnings for the next quarter are −0.41 USD per share. See more details about Trevena, Inc. earnings.
Trevena, Inc. revenue for the last quarter amounts to ‪20.00 K‬ USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
TRVN net income for the last quarter is ‪−7.68 M‬ USD, while the quarter before that showed ‪−16.51 M‬ USD of net income which accounts for 53.49% change. Track more Trevena, Inc. financial stats to get the full picture.
No, TRVN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jun 25, 2024, the company has 23.00 employees. See our rating of the largest employees — is Trevena, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Trevena, Inc. EBITDA is ‪−34.42 M‬ USD, and current EBITDA margin is ‪−1.10 K‬%. See more stats in Trevena, Inc. financial statements.
Like other stocks, TRVN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Trevena, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Trevena, Inc. technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Trevena, Inc. stock shows the sell signal. See more of Trevena, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.